Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Crit Care Med. 2012 Oct;40(10):2788–2796. doi: 10.1097/CCM.0b013e31825b8ade

Table 3.

Changes in nighttime sedation dose and odds ratios of liberation from mechanical ventilation #

Percentiles Successful SBT Successful extubation
Variables 10th 90th OR (95% CI) P value OR (95% CI) P value
Change in sedative dosing at night
   Benzodiazepine dose, mg/hr −0.19 0.25 0.4 (0.2 – 0.8) <0.01 0.7 (0.3 – 1.7) 0.38
   Propofol dose, mcg/kg/min −7.7 5.7 0.8 (0.5 – 1.4) 0.43 1.0 (0.6 – 1.6) 0.94
Daytime sedative dosing
    Benzodiazepine dose, mg/hr 0 2.4 nonlinear* <0.01 nonlinear* 0.02
    Propofol dose, mcg/kg/min 0 40.1 0.4 (0.2 – 1.1) 0.09 1.2 (0.5 – 2.6) 0.67
#

N=192 observations for extubation model, N=173 observations for SBT model

*

Because these associations are nonlinear, the magnitude of the associations cannot be summarized using a single odds ratio but are displayed in Figures 2 and 3.

Interpretive example: The odds ratios (ORs) reflect the change in odds of the outcome that was independently associated with a change in the exposure from the 10th percentile value to the 90th percentile value. For example, a nighttime increase in benzodiazepine dose of 0.25 mg/hr, compared to a decrease of 0.19 mg/hr, was independently associated with a 60% reduction in odds of successful spontaneous breathing trial on the day following sedative exposure.